SCHEMBL7744662

SCHEMBL7744662

CC(=O)Nc1oc(-c2ccc(-c3ccccc3)cc2O)nc1-c1ccccc1Cl

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 7/20 0.61
FLT1 P17948 1/20 0.61
FLT4 P35916 1/20 0.61
KDM4E B2RXH2 3/20 0.43
APOBEC3A P31941 1/20 0.43
GFER P55789 1/20 0.43
HDAC1 Q13547 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43
AGPAT2 O15120 1/20 0.43
CNR1 P21554 2/20 0.43
CNR2 P34972 1/20 0.42
SMO Q99835 1/20 0.42
ALOX15 P16050 1/20 0.40
RAB9A P51151 2/20 0.40
MAPT P10636 2/20 0.39
NPC1 O15118 1/20 0.39
POLB P06746 1/20 0.39
NR4A2 P43354 2/20 0.39
RXRA P19793 1/20 0.39
RXRB P28702 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7746639 0.92 KDR (0.61) KDRFLT1FLT4KDM4EAPOBEC3A
SCHEMBL7744663 0.89 KDR (0.76) KDRFLT1FLT4KDM4EAPOBEC3A
SCHEMBL7746649 0.88 KDR (0.47) KDRFLT1FLT4KDM4EHDAC1
SCHEMBL7739087 0.88 KDR (0.69) KDRFLT1FLT4KDM4EAPOBEC3A
SCHEMBL7746611 0.88 KDR (0.50) KDRFLT1FLT4MAPTALDH1A1
SCHEMBL7739078 0.86 KDR (0.68) KDRFLT1FLT4KDM4EAPOBEC3A
SCHEMBL7744162 0.85 KDR (0.45) KDRFLT1FLT4KDM4EHDAC1
SCHEMBL7744664 0.83 KDR (0.55) KDRFLT1FLT4KDM4ECNR1
SCHEMBL7739014 0.82 KDR (0.63) KDRFLT1FLT4KDM4EAPOBEC3A
SCHEMBL7746616 0.81 KDR (0.65) KDRFLT1FLT4KDM4EAPOBEC3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed